XML 36 R23.htm IDEA: XBRL DOCUMENT v3.25.1
Research and Development Activity (Tables)
 3 Months Ended
Mar. 31, 2025
Research and Development Activity [Abstract]  
Schedule of INKmune License Agreement Milestone Payments in Consideration for the Patent Rights In consideration for the patent rights, the Company agreed to the following milestone payments:
(in thousands)    
Each Phase I initiation  $25 
Each Phase II initiation  $250 
Each Phase III initiation  $350 
Each NDA/EMA filing  $1,000 
Each NDA/EMA awarded  $9,000 
Schedule of PITT Agreement Licensee is Required to make Milestone Payments

Moreover, under the PITT Agreement the Licensee is required to make milestone payments as follows:

 

(in thousands)    
Each Phase I initiation  $50 
Each Phase III initiation  $500 
First commercial sale of product making use of licensed technology  $1,250